The impact of COVID-19 has increased focus in healthcare facilities on managing patient care with a sharp eye on resources. With an emphasis on improving OR efficiency, minimising prolonged stays, reducing re-admissions and preventable complications is vital to patient flow and facility economics. As you look for solutions that provide extended value, learn how PREVENA™ Therapy can help protect you, your patients, and your practice beyond the incision site.
PREVENA™ Therapy manages and protects surgical incisions in high risk patients. Under -125mmHg of negative pressure, the Reticulated Open Cell Foam dressing collapses to its geometric center, bringing incision edges together to reduce lateral tension and improve fluid management.
The most clinically validated closed incision negative pressure therapy with over 80+ publications and growing, PREVENA™ Therapy can aid in reducing the costly financial burden of complications such as SSIs.
PREVENA™ Therapy helps provide protection from outside sources of infection, ensuring the effective management and healing of surgical incisions in patients.
Learn how PREVENA™ Therapy is uniquely engineered to empower incision management that works to protect patients, surgeons, staff, practices and hospitals during the COVID-19 pandemic.